ADPT Stock Analysis: Buy, Sell, or Hold?
ADPT - Adaptive Biotechnologies Corporation Common Stock
$13.81
-0.88 (-5.99%)
▼
5d:
-3.22%
30d:
+3.06%
90d:
-12.43%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When ADPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ADPT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ADPT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ADPT is currently trading at $13.81, which is considered slightly low relative to its 30-day fair value range of $13.60 to $14.59.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $12.98, while resistance sits at $15.06. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: ADPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.57 (+49.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $12.98, while resistance sits at $15.06. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: ADPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.57 (+49.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$13.60 -
$14.59
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 49.0% below Wall St target ($20.57)
Trading Range Analysis
30-Day Trading Range
$13.60 -
$14.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$12.98
Resistance Level
$15.06
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-56.76
Wall Street Target
$20.57
(+49.0%)
Revenue Growth (YoY)
51.0%
Profit Margin
-21.5%
Share & Embed Analysis
Last updated: May 10, 2026 12:00 PM ET
Data refreshes hourly during market hours. Next update: 1:00 PM
Data refreshes hourly during market hours. Next update: 1:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Rubinstein
SELL
19060 shares
2026-04-24
Julie Rubinstein
SELL
19060 shares
2026-04-22
Julie Rubinstein
SELL
30941 shares
2026-04-21
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 55 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 61 BUY |
